UFP Technologies, Inc. (UFPT)
USD 204.59
(-0.48%)
USD 204.59
(-0.48%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 28 Million USD | -45.1% |
| 2022 | 51 Million USD | -34.71% |
| 2021 | 78.11 Million USD | 7440.35% |
| 2020 | 1.03 Million USD | -57.12% |
| 2019 | 2.41 Million USD | -89.16% |
| 2018 | 22.28 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 859 Thousand USD | -54.14% |
| 2014 | 1.87 Million USD | -34.67% |
| 2013 | 2.86 Million USD | -65.52% |
| 2012 | 8.31 Million USD | 47.45% |
| 2011 | 5.63 Million USD | -17.65% |
| 2010 | 6.84 Million USD | -8.73% |
| 2009 | 7.5 Million USD | 54.62% |
| 2008 | 4.85 Million USD | -22.63% |
| 2007 | 6.27 Million USD | -9.39% |
| 2006 | 6.92 Million USD | -9.53% |
| 2005 | 7.64 Million USD | 2.04% |
| 2004 | 7.49 Million USD | -7.66% |
| 2003 | 8.11 Million USD | 18.52% |
| 2002 | 6.85 Million USD | 0.35% |
| 2001 | 6.82 Million USD | -10.05% |
| 2000 | 7.58 Million USD | 181.09% |
| 1999 | 2.7 Million USD | 28.57% |
| 1998 | 2.1 Million USD | -34.38% |
| 1997 | 3.2 Million USD | 0.0% |
| 1996 | 3.2 Million USD | 28.0% |
| 1995 | 2.5 Million USD | 56.25% |
| 1994 | 1.6 Million USD | -15.79% |
| 1993 | 1.9 Million USD | 5.56% |
| 1992 | 1.8 Million USD | -18.18% |
| 1991 | 2.2 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 35.13 Million USD | 17.12% |
| 2024 Q3 | 199.5 Million USD | 467.81% |
| 2024 Q1 | 29.91 Million USD | 7.14% |
| 2023 Q3 | 50.46 Million USD | -4.78% |
| 2023 Q2 | 53 Million USD | -5.36% |
| 2023 Q1 | 56 Million USD | 9.8% |
| 2023 FY | 28 Million USD | -45.1% |
| 2023 Q4 | 28 Million USD | -44.51% |
| 2022 FY | 51 Million USD | -34.71% |
| 2022 Q4 | 51 Million USD | -33.94% |
| 2022 Q3 | 77.2 Million USD | -27.45% |
| 2022 Q2 | 106.41 Million USD | 8.6% |
| 2022 Q1 | 97.98 Million USD | 25.44% |
| 2021 Q3 | 510 Thousand USD | -34.7% |
| 2021 Q4 | 78.11 Million USD | 15217.25% |
| 2021 FY | 78.11 Million USD | 7440.35% |
| 2021 Q2 | 781 Thousand USD | -26.11% |
| 2021 Q1 | 1.05 Million USD | 2.03% |
| 2020 Q3 | 1.27 Million USD | -16.31% |
| 2020 FY | 1.03 Million USD | -57.12% |
| 2020 Q4 | 1.03 Million USD | -18.62% |
| 2020 Q1 | 1.68 Million USD | -30.17% |
| 2020 Q2 | 1.52 Million USD | -9.84% |
| 2019 Q4 | 2.41 Million USD | -80.1% |
| 2019 Q3 | 12.14 Million USD | -12.37% |
| 2019 Q2 | 13.85 Million USD | -28.15% |
| 2019 Q1 | 19.28 Million USD | -13.46% |
| 2019 FY | 2.41 Million USD | -89.16% |
| 2018 Q3 | 31 Million USD | -15.56% |
| 2018 Q1 | 46.42 Million USD | 0.0% |
| 2018 Q2 | 36.71 Million USD | -20.92% |
| 2018 Q4 | 22.28 Million USD | -28.11% |
| 2018 FY | 22.28 Million USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q2 | 345 Thousand USD | -42.79% |
| 2016 Q4 | - USD | -100.0% |
| 2016 Q3 | 84 Thousand USD | -75.65% |
| 2016 Q1 | 603 Thousand USD | -29.8% |
| 2016 FY | - USD | -100.0% |
| 2015 Q4 | 859 Thousand USD | -22.75% |
| 2015 Q2 | 1.36 Million USD | -15.61% |
| 2015 FY | 859 Thousand USD | -54.14% |
| 2015 Q3 | 1.11 Million USD | -18.71% |
| 2015 Q1 | 1.62 Million USD | -13.45% |
| 2014 Q1 | 2.62 Million USD | -8.62% |
| 2014 FY | 1.87 Million USD | -34.67% |
| 2014 Q4 | 1.87 Million USD | -11.78% |
| 2014 Q3 | 2.12 Million USD | -10.5% |
| 2014 Q2 | 2.37 Million USD | -9.47% |
| 2013 Q3 | 7.73 Million USD | -4.8% |
| 2013 Q2 | 8.12 Million USD | -4.56% |
| 2013 Q1 | 8.51 Million USD | 2.41% |
| 2013 Q4 | 2.86 Million USD | -62.94% |
| 2013 FY | 2.86 Million USD | -65.52% |
| 2012 Q3 | 5.2 Million USD | -2.71% |
| 2012 FY | 8.31 Million USD | 47.45% |
| 2012 Q1 | 5.49 Million USD | -2.57% |
| 2012 Q2 | 5.34 Million USD | -2.65% |
| 2012 Q4 | 8.31 Million USD | 59.79% |
| 2011 FY | 5.63 Million USD | -17.65% |
| 2011 Q1 | 6.69 Million USD | -2.22% |
| 2011 Q4 | 5.63 Million USD | -2.51% |
| 2011 Q3 | 5.78 Million USD | -2.45% |
| 2011 Q2 | 5.92 Million USD | -11.44% |
| 2010 Q1 | 7.34 Million USD | -2.08% |
| 2010 FY | 6.84 Million USD | -8.73% |
| 2010 Q3 | 7 Million USD | -2.6% |
| 2010 Q4 | 6.84 Million USD | -2.22% |
| 2010 Q2 | 7.18 Million USD | -2.13% |
| 2009 Q4 | 7.5 Million USD | -2.04% |
| 2009 Q2 | 7.77 Million USD | -1.94% |
| 2009 Q1 | 7.92 Million USD | 63.44% |
| 2009 FY | 7.5 Million USD | 54.62% |
| 2009 Q3 | 7.65 Million USD | -1.51% |
| 2008 Q1 | 5.9 Million USD | -5.79% |
| 2008 FY | 4.85 Million USD | -22.63% |
| 2008 Q4 | 4.85 Million USD | -6.66% |
| 2008 Q3 | 5.19 Million USD | -6.19% |
| 2008 Q2 | 5.54 Million USD | -6.21% |
| 2007 Q3 | 6.63 Million USD | -5.25% |
| 2007 Q4 | 6.27 Million USD | -5.43% |
| 2007 Q1 | 6.57 Million USD | -4.94% |
| 2007 FY | 6.27 Million USD | -9.39% |
| 2007 Q2 | 6.99 Million USD | 6.38% |
| 2006 Q1 | 7.38 Million USD | -3.46% |
| 2006 Q3 | 7.29 Million USD | -4.53% |
| 2006 Q4 | 6.92 Million USD | -5.13% |
| 2006 FY | 6.92 Million USD | -9.53% |
| 2006 Q2 | 7.64 Million USD | 3.48% |
| 2005 Q1 | 7.1 Million USD | -5.25% |
| 2005 Q4 | 7.64 Million USD | 11.02% |
| 2005 Q2 | 7.32 Million USD | 3.09% |
| 2005 FY | 7.64 Million USD | 2.04% |
| 2005 Q3 | 6.89 Million USD | -5.9% |
| 2004 Q2 | 7.54 Million USD | -3.99% |
| 2004 Q4 | 7.49 Million USD | -1.95% |
| 2004 FY | 7.49 Million USD | -7.66% |
| 2004 Q1 | 7.85 Million USD | -3.24% |
| 2004 Q3 | 7.64 Million USD | 1.36% |
| 2003 Q4 | 8.11 Million USD | 4.96% |
| 2003 FY | 8.11 Million USD | 18.52% |
| 2003 Q1 | 7.51 Million USD | 9.73% |
| 2003 Q3 | 7.73 Million USD | 0.44% |
| 2003 Q2 | 7.7 Million USD | 2.45% |
| 2002 Q3 | 6.08 Million USD | -6.29% |
| 2002 Q4 | 6.85 Million USD | 12.5% |
| 2002 Q2 | 6.49 Million USD | -2.44% |
| 2002 Q1 | 6.66 Million USD | -2.43% |
| 2002 FY | 6.85 Million USD | 0.35% |
| 2001 FY | 6.82 Million USD | -10.05% |
| 2001 Q1 | 7.16 Million USD | -5.66% |
| 2001 Q2 | 7.59 Million USD | 6.12% |
| 2001 Q3 | 7.22 Million USD | -4.95% |
| 2001 Q4 | 6.82 Million USD | -5.47% |
| 2000 FY | 7.58 Million USD | 181.09% |
| 2000 Q1 | 8.38 Million USD | 210.48% |
| 2000 Q2 | 7.81 Million USD | -6.82% |
| 2000 Q3 | 7.95 Million USD | 1.88% |
| 2000 Q4 | 7.58 Million USD | -4.63% |
| 1999 Q2 | 1.5 Million USD | -11.76% |
| 1999 Q4 | 2.7 Million USD | 125.0% |
| 1999 Q3 | 1.2 Million USD | -20.0% |
| 1999 FY | 2.7 Million USD | 28.57% |
| 1999 Q1 | 1.7 Million USD | -19.05% |
| 1998 Q1 | 3 Million USD | -6.25% |
| 1998 Q4 | 2.1 Million USD | -16.0% |
| 1998 FY | 2.1 Million USD | -34.38% |
| 1998 Q3 | 2.5 Million USD | -7.41% |
| 1998 Q2 | 2.7 Million USD | -10.0% |
| 1997 Q2 | 2.9 Million USD | -6.45% |
| 1997 Q1 | 3.1 Million USD | -3.13% |
| 1997 Q3 | 2.7 Million USD | -6.9% |
| 1997 Q4 | 3.2 Million USD | 18.52% |
| 1997 FY | 3.2 Million USD | 0.0% |
| 1996 Q3 | 2.7 Million USD | -10.0% |
| 1996 FY | 3.2 Million USD | 28.0% |
| 1996 Q4 | 3.2 Million USD | 18.52% |
| 1996 Q2 | 3 Million USD | 30.43% |
| 1996 Q1 | 2.3 Million USD | -8.0% |
| 1995 FY | 2.5 Million USD | 56.25% |
| 1995 Q1 | 1.5 Million USD | -6.25% |
| 1995 Q3 | 1.7 Million USD | 0.0% |
| 1995 Q2 | 1.7 Million USD | 13.33% |
| 1995 Q4 | 2.5 Million USD | 47.06% |
| 1994 Q1 | 1.8 Million USD | -5.26% |
| 1994 FY | 1.6 Million USD | -15.79% |
| 1994 Q3 | 1.7 Million USD | -5.56% |
| 1994 Q4 | 1.6 Million USD | -5.88% |
| 1994 Q2 | 1.8 Million USD | 0.0% |
| 1993 Q4 | 1.9 Million USD | 0.0% |
| 1993 FY | 1.9 Million USD | 5.56% |
| 1992 Q4 | 1.8 Million USD | 0.0% |
| 1992 FY | 1.8 Million USD | -18.18% |
| 1991 Q4 | 2.2 Million USD | 0.0% |
| 1991 FY | 2.2 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| BrainsWay Ltd. | 239 Thousand USD | -11615.481% |
| Envoy Medical, Inc. | 404 Thousand USD | -6830.693% |
| Bioventus Inc. | 366.99 Million USD | 92.371% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| MaxCyte, Inc. | 17.96 Million USD | -55.824% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Cerus Corporation | 59.79 Million USD | 53.174% |
| Sight Sciences, Inc. | 31.7 Million USD | 11.694% |
| SI-BONE, Inc. | 36.06 Million USD | 22.362% |
| CVRx, Inc. | 30.38 Million USD | 7.84% |
| OrthoPediatrics Corp. | 13.45 Million USD | -108.039% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -592.213% |
| Orthofix Medical Inc. | 93.1 Million USD | 69.927% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -2653.385% |
| Acutus Medical, Inc. | 32.65 Million USD | 14.252% |
| Talis Biomedical Corporation | 16.78 Million USD | -66.806% |
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 22.442% |
| electroCore, Inc. | 537 Thousand USD | -5114.153% |
| Inogen, Inc. | 18.27 Million USD | -53.257% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -13970.352% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -7598.145% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| PAVmed Inc | 2.96 Million USD | -845.946% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -350.595% |
| RxSight, Inc. | 1.21 Million USD | -2212.139% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -2150.804% |
| Treace Medical Concepts, Inc. | 53 Million USD | 47.178% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -1740.894% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -233233.333% |
| IceCure Medical Ltd | 376 Thousand USD | -7346.809% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -50547.565% |
| TELA Bio, Inc. | 40.51 Million USD | 30.89% |
| Venus Concept Inc. | 70.79 Million USD | 60.446% |
| LivaNova PLC | 568.54 Million USD | 95.075% |
| 908 Devices Inc. | 3.92 Million USD | -612.65% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 94.521% |
| Nemaura Medical Inc. | 3.08 Million USD | -806.838% |
| NeuroPace, Inc. | 56.95 Million USD | 50.838% |
| LENSAR, Inc. | 1.75 Million USD | -1500.0% |
| Apyx Medical Corporation | 33.18 Million USD | 15.625% |
| Cutera, Inc. | 418.69 Million USD | 93.313% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -86.121% |
| BioSig Technologies, Inc. | 103 Thousand USD | -27084.466% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -4.074% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -181.435% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 98.115% |
| Axonics, Inc. | 25.84 Million USD | -8.359% |
| Outset Medical, Inc. | 134.59 Million USD | 79.197% |
| IRIDEX Corporation | 1.75 Million USD | -1499.086% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 45.461% |
| IRadimed Corporation | 1.61 Million USD | -1633.66% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -15809.091% |
| INVO Bioscience, Inc. | 6.77 Million USD | -313.218% |
| Telesis Bio, Inc. | 5.26 Million USD | -431.41% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -368.91% |
| Varex Imaging Corporation | 464.2 Million USD | 93.968% |
| Quipt Home Medical Corp. | 60.82 Million USD | 53.963% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -4661.905% |
| Pulmonx Corporation | 35.08 Million USD | 20.203% |
| Dynatronics Corporation | 3.25 Million USD | -759.297% |
| Modular Medical, Inc. | 817 Thousand USD | -3327.173% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -18443.046% |
| Semler Scientific, Inc. | 70 Thousand USD | -39900.0% |
| InMode Ltd. | 6.61 Million USD | -323.408% |
| Bruker Corporation | 1.14 Billion USD | 97.554% |
| Cytosorbents Corporation | 2.54 Million USD | -1001.124% |
| DexCom, Inc. | 2.57 Billion USD | 98.912% |
| Align Technology, Inc. | 96.96 Million USD | 71.124% |
| Viveve Medical, Inc. | 5.12 Million USD | -446.448% |
| ZimVie Inc. | 508.79 Million USD | 94.497% |
| Movano Inc. | 15.00 USD | -186666566.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -54.483% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 92.976% |
| Profound Medical Corp. | 4.97 Million USD | -462.88% |
| Insulet Corporation | 1.36 Billion USD | 97.951% |
| enVVeno Medical Corporation | 1.06 Million USD | -2531.579% |
| Surmodics, Inc. | 29.4 Million USD | 4.778% |
| iCAD, Inc. | 273 Thousand USD | -10156.41% |
| Nuwellis, Inc. | 221 Thousand USD | -12569.683% |
| Biotricity, Inc. | 10.85 Million USD | -157.926% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 19.886% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -4209.343% |
| InspireMD, Inc. | 1.03 Million USD | -2597.495% |
| PAVmed Inc. | 2.96 Million USD | -845.946% |
| BIOLASE, Inc. | 13.98 Million USD | -100.215% |
| Beyond Air, Inc. | 14.72 Million USD | -90.204% |
| FONAR Corporation | 37.92 Million USD | 26.179% |
| AxoGen, Inc. | 46.6 Million USD | 39.918% |
| Vivani Medical, Inc. | 19.31 Million USD | -44.98% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 37.237% |
| Inari Medical, Inc. | 30.35 Million USD | 7.758% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -6350.944% |
| Tenon Medical, Inc. | 428 Thousand USD | -6442.056% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -2694.411% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -1201.006% |
| AdaptHealth Corp. | 2.09 Billion USD | 98.663% |
| Sintx Technologies, Inc. | 3.68 Million USD | -659.425% |
| Quanterix Corporation | 37.22 Million USD | 24.778% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -4661.905% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -4597.987% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 96.862% |
| TransMedics Group, Inc. | 506.2 Million USD | 94.469% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -4512.85% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -30175.18% |
| Hyperfine, Inc. | 64 Thousand USD | -43650.0% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 85.165% |
| Biomerica, Inc. | 459 Thousand USD | -6000.218% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -6129.379% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -14637.85% |
| Silk Road Medical, Inc | 75.62 Million USD | 62.976% |